We have drastically cut our EBITDA estimates for FY21/FY22 as 1) fixed cost absorption will be a challenge in a weak demand environment (inventory utilization for 35 legacy/17 batch 1/21batch 2 stations is expected to be 55%/15%/10% in FY21E) 2) recovery in non-FCT business will be back ended...